Correlation Between Agilent Technologies and ArriVent BioPharma,
Can any of the company-specific risk be diversified away by investing in both Agilent Technologies and ArriVent BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agilent Technologies and ArriVent BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agilent Technologies and ArriVent BioPharma, Common, you can compare the effects of market volatilities on Agilent Technologies and ArriVent BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agilent Technologies with a short position of ArriVent BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agilent Technologies and ArriVent BioPharma,.
Diversification Opportunities for Agilent Technologies and ArriVent BioPharma,
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Agilent and ArriVent is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Agilent Technologies and ArriVent BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ArriVent BioPharma, and Agilent Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agilent Technologies are associated (or correlated) with ArriVent BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ArriVent BioPharma, has no effect on the direction of Agilent Technologies i.e., Agilent Technologies and ArriVent BioPharma, go up and down completely randomly.
Pair Corralation between Agilent Technologies and ArriVent BioPharma,
Taking into account the 90-day investment horizon Agilent Technologies is expected to under-perform the ArriVent BioPharma,. But the stock apears to be less risky and, when comparing its historical volatility, Agilent Technologies is 2.12 times less risky than ArriVent BioPharma,. The stock trades about 0.0 of its potential returns per unit of risk. The ArriVent BioPharma, Common is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 1,800 in ArriVent BioPharma, Common on August 27, 2024 and sell it today you would earn a total of 945.00 from holding ArriVent BioPharma, Common or generate 52.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 42.74% |
| Values | Daily Returns |
Agilent Technologies vs. ArriVent BioPharma, Common
Performance |
| Timeline |
| Agilent Technologies |
| ArriVent BioPharma, |
Agilent Technologies and ArriVent BioPharma, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Agilent Technologies and ArriVent BioPharma,
The main advantage of trading using opposite Agilent Technologies and ArriVent BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agilent Technologies position performs unexpectedly, ArriVent BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ArriVent BioPharma, will offset losses from the drop in ArriVent BioPharma,'s long position.| Agilent Technologies vs. Fonar | Agilent Technologies vs. Burning Rock Biotech | Agilent Technologies vs. Sera Prognostics | Agilent Technologies vs. Exagen Inc |
| ArriVent BioPharma, vs. Tesla Inc | ArriVent BioPharma, vs. Yuexiu Transport Infrastructure | ArriVent BioPharma, vs. Afya | ArriVent BioPharma, vs. Lindblad Expeditions Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |